|
|
|
| Efficacy of Vacuum-assisted Minimally Invasive Rotational Excision for Benign Breast Tumors under Ultrasound and Its Effect on Tumor Markers |
| Wu Yun |
| Wuhan hankou Hospital, Thyroid and Breast Surgery, Wuhan Hubei 430012 |
|
|
|
|
Abstract Objective to investigate the effect of vacuum-assisted minimally invasive rotary excision(VAB) under ultrasound in the treatment of benign breast tumors. Methods 80 patients with benign breast tumors treated in our hospital from July 2020 to June 2023 were selected and divided into 40 cases each in the control group(open surgery) and the study group(VAB) by applying the method of random number table,comparing the surgical indexes,pain factors [Neuropeptide Y(NPY),5-Hydroxytryptophan(5-HT),Prostaglandin E2(PGE2)],Visual Analog Scale(VAS) score,tumor markers [carcinoembryonic antigen(CEA),glycan antigen 125(CA125)],and complications. Results Surgical time,incision length,and bleeding were lower in the study group than in the control group,and the differences were statistically significant(P<0.05).Preoperatively,the difference between the two pain factors was not statistically significant(P>0.05);3d postoperatively,NPY,5-HT,and PGE2 were elevated in both groups,and NPY,5-HT,and PGE2 were higher in the control group than in the study group,with statistically significant differences(P<0.05).Postoperatively,VAS was lower in the study group than in the control group in 1d,3d and 7d,and the difference was statistically significant(P<0.05).Preoperatively,the difference between the two tumor markers was not statistically significant(P>0.05);postoperatively,CEA and CA125 were reduced in both groups,and the difference was statistically significant(P<0.05);the difference in CEA and CA125 between the groups was not statistically significant(P>0.05).Complications in the study group were lower than those in the control group,and the difference was statistically significant(P<0.05). Conclusion Benign breast tumors treated with VAB can reduce the degree of pain,promote recovery,and have no effect on tumor markers.
|
|
Received: 30 March 2026
|
|
|
|
|
|
[1] LI Q,LI G,ZHOU Y,et al.Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.[J].Journal of proteome research,2019,18(6):2559-2570. [2] 汪茜,许涛.超声引导下麦默通乳腺微创旋切术治疗乳腺良性肿瘤疗效及对乳房外观美观度与肿瘤标志物水平影响的研究[J].中国医学装备,2022,19(8):104-108. [3] 张军,裴静.超声引导下真空辅助旋切手术治疗乳腺良性肿瘤的疗效及安全性评价[J].华南国防医学杂志,2021,35(7):489-492. [4] 石剑,魏建南,李萍,等.超声引导真空辅助旋切与局部扩大切除治疗乳腺良性叶状肿瘤的疗效比较[J].中国微创外科杂志,2021(7):615-618. [5] 张海燕,史红杰,马二梅,等.消瘤汤佐治子宫肌瘤的疗效及对肿瘤标志物、炎症因子和纤维化因子的影响[J].四川中医,2020,38(3):182-185. [6] 李静,周恩相,莫濡冰.乳腺肿块患者麦默通微创旋切术的应用及对患者微血管密度与血管内皮因子的影响[J].解放军预防医学杂志,2019,37(5):75-76. [7] 马靖靖,宋文华,刘小五,等.超声引导下真空辅助旋切手术治疗乳腺良性叶状肿瘤的疗效及术后局部复发的影响因素分析[J].现代生物医学进展,2020,20(22):4279-4282,4391. [8] AHMAY,BRAAMA.Alteration of BRCA-1 tumor suppressor gene expression in serous and mucinous ovarian neoplasms in the benign-borderline-malignant pathway[J].Current Problems in Cancer,2019,43(4):377-385. [9] 庞宏欣,王卫,李艳红.超声引导下微创旋切术对乳腺良性肿瘤患者术后恢复与并发症风险的影响分析[J].山西医药杂志,2022,51(16):1827-1829. [10] 刘春,刘云冲,于振彬,等.超声辅助麦默通乳腺微创旋切术对老年乳腺良性肿瘤患者血清疼痛因子及炎症因子水平的影响[J].医学临床研究,2022,39(1):77-80. [11] 杜璐迪,刘翔,王莉娟,等.乳管镜联合B超引导下微创旋切术治疗乳腺导管内良性肿瘤的疗效和安全性[J].中国妇幼保健,2022,37(7):1341-1343. [12] 王六林,王园园,李珍,等.麦默通微创旋切术治疗良性乳腺肿物的效果及对术后疼痛症状的影响[J].河北医药,2022,44(16):2508-2510. [13] MEI J,HU Y,JIANG X,et al.Ultrasound-guided Vacuum-assisted Biopsy Versus Surgical Resection in Patients With Breast Desmoid Tumor[J].Journal of Surgical Research,2021,261(Suppl 10):400-406. [14] 周颖,刘韬.超声引导MMT微创旋切术治疗对女性良性乳腺肿块围手术期指标术后疼痛瘢痕及并发症的影响[J].河北医学,2023,29(4):663-667. [15] 周永刚,段云友,赵华栋,等.超声术前评估及精准定位在真空辅助微创旋切系统治疗乳腺多发良性包块中的应用[J].临床超声医学杂志,2019,21(3):212-214. [16] 张少玲,连臻强,余海云,等.乳腺良性叶状肿瘤真空辅助旋切与开放手术对术后局部复发的影响[J].中华外科杂志,2020,58(2):110-113. |
| [1] |
. [J]. journal1, 2026, 46(2): 77-79. |
| [2] |
Kang Lihua, Zhai Fengyu, Liu Yuefen. The Efficacy of Sintilimab Combined with Platinum-based Chemotherapy in the Treatment of Advanced NSCLC Patients and Its Influence on Serum Notch1 and Dickkopf-1 Levels[J]. journal1, 2026, 46(1): 20-24. |
| [3] |
. [J]. journal1, 2026, 46(1): 74-76. |
| [4] |
Zhou Guohui. The Effect of Lenvatinib Combined with Xindilimab on Tumor Marker Levels and Survival in Patients with Advanced Liver Cancer[J]. journal1, 2025, 45(2): 4-7. |
| [5] |
Wang Lidong, Wang Binbin, Duan Zheng, Zhang Juan. Effects of the Addition and Subtraction of Zhenggan Huazheng Tang Together with Western Drug Therapy on Liver Function and T Lymphocyte Subpopulations in Patients with Primary Hepatocellular Carcinoma[J]. journal1, 2024, 44(4): 112-115. |
| [6] |
Ding Yanhua, Men Shuai, Zhang Jiangxia, Zhang Xu, Zhang Shancun, Liu Lu, Lv Hongwei, Xiao Zhenghong. Clinical Efficacy of Bevacizumab Combined with Anlotinib in The Treatment of Non-small Cell Lung Cancer and Its Influence on Immune Status[J]. journal1, 2024, 44(1): 41-44. |
|
|
|
|